Medical News

RSS

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

6 May 2010

Teleflex Medical voluntarily recalls certain lots of AQUA+FLEX Hygroscopic Condenser Humidifier

Teleflex Medical has announced a worldwide voluntary recall initiated on March 19, 2010, affecting certain lot numbers of the Teleflex Medical AQUA+FLEX Hygroscopic Condenser Humidifier (HCH) (catalog number 1570) a passive humidifier indicated for use to effectively warm and humidify inspired gas during mechanical ventilation.

6 May 2010

Curis reports net income of $4.8M for first-quarter 2010

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the first quarter ended March 31, 2010.

6 May 2010

Columbia Laboratories reports 34% increase in net revenues from U.S. sales of progesterone products

Columbia Laboratories, Inc. today announced financial results for the three-month period ended March 31, 2010.

6 May 2010

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

Percepta Associates Inc. announces the release of Series Three of its Gene Expression Profiling Life Science Dashboard market research report. Unique to the Percepta report, Series Three offers comparisons to the findings of Series One (February 2007) and Series Two (April 2008).

6 May 2010

MOCON's net sales for first-quarter 2010 increase 15% to $7,093,000

MOCON, Inc. today reported its operating results for the quarter ended March 31, 2010.

6 May 2010

Cytori's first-quarter total revenues increase to $4.4 million

Cytori Therapeutics is reporting its first quarter financial results.

6 May 2010

PurGenesis announces positive results from Phase I clinical trial of PUR0110 for ulcerative colitis

PurGenesis Technologies Inc. announced today positive results from a Phase I clinical trial on PUR0110, the Company's lead investigational new drug for the treatment of ulcerative colitis. This successful trial was designed to evaluate the safety and maximum tolerated dose of PUR0110.

6 May 2010

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

6 May 2010

Public need to be informed of nanotechnology's risks as well as benefits: Survey

A new national survey on public attitudes toward medical applications and physical enhancements that rely on nanotechnology shows that support for the technology increases when the public is informed of the technology's risks as well as its benefits - at least among those people who have heard of nanotechnology.

6 May 2010

Symmetry Medical's first-quarter 2010 revenues up 10.6%

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2010 financial results for the three-month period ended April 3, 2010.

6 May 2010

Momenta Pharmaceuticals first-quarter net loss decreases to $16.1 million

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended March 31, 2010.

6 May 2010

Investigators demonstrate safety and efficacy of targeted medication to shrink advanced kidney cancers

A multicenter team of investigators led by the University of California, San Diego School of Medicine has demonstrated, for the first time, the safety and efficacy of a targeted medication to shrink advanced kidney cancers prior to partial kidney removal and reconstruction. Their findings were published in the April 2010 online edition of BJU International.

6 May 2010

Aeterna Zentaris granted FDA orphan-drug designation for AEZS-108 in ovarian cancer

Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received from the U.S. Food and Drug Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.

6 May 2010

NanoString Technologies receives ISO 13485:2003 certification

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices.

From NanoString Technologies 6 May 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010

CombinatoRx, Incorporated today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

Intellect Neurosciences signs debt settlement agreement with CARBOGEN AMCIS AG

Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today that it has reached a debt settlement agreement with CARBOGEN AMCIS AG, one of Intellect's largest trade creditors, in connection with prior services rendered.

6 May 2010

Medical News

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

Teleflex Medical voluntarily recalls certain lots of AQUA+FLEX Hygroscopic Condenser Humidifier

Curis reports net income of $4.8M for first-quarter 2010

Columbia Laboratories reports 34% increase in net revenues from U.S. sales of progesterone products

Series Three of Percepta's Gene Expression Profiling Life Science Dashboard market research report

MOCON's net sales for first-quarter 2010 increase 15% to $7,093,000

Cytori's first-quarter total revenues increase to $4.4 million

PurGenesis announces positive results from Phase I clinical trial of PUR0110 for ulcerative colitis

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

Public need to be informed of nanotechnology's risks as well as benefits: Survey

Symmetry Medical's first-quarter 2010 revenues up 10.6%

Momenta Pharmaceuticals first-quarter net loss decreases to $16.1 million

Investigators demonstrate safety and efficacy of targeted medication to shrink advanced kidney cancers

Aeterna Zentaris granted FDA orphan-drug designation for AEZS-108 in ovarian cancer

NanoString Technologies receives ISO 13485:2003 certification

CombinatoRx reports $41.3M total revenue for first-quarter 2010

Intellect Neurosciences signs debt settlement agreement with CARBOGEN AMCIS AG

Gentiva Health Services first-quarter total net revenues up 7.5% to $297.1 million

Biovail reports 27% increase in first-quarter 2010 total revenues

ArQule reports net loss of $9,752,000 for first-quarter 2010

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News